NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ)

$22.8 0.94 (4.3001%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 56

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) News Sources

NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026

26-08-2026

yahoo.com

external link

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September

02-09-2026

yahoo.com

external link

Novartis Trial Failure Sparks Biopharma Options Frenzy

08-09-2026

yahoo.com

external link

How Novartis' Double-Stacked Failures Reverberated Through Biopharma

08-09-2026

yahoo.com

external link

Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma

07-07-2026

yahoo.com

external link

Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026

08-06-2026

yahoo.com

external link

A Look At NewAmsterdam Pharma (NAMS) Valuation After Recent Share Price Weakness

11-06-2026

yahoo.com

external link

NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026

01-07-2026

yahoo.com

external link

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

24-07-2026

yahoo.com

external link

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03-09-2026

yahoo.com

external link

NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) Sentiment Trend

0 25 50 75 100 75 81 2 2 74 78 56 73 65 59 26-08-2026 02-09-2026 08-09-2026 07-07-2026 08-06-2026 11-06-2026 01-07-2026 24-07-2026 03-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) FAQs

toggle

What is the current price of NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ)?

The current price of NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) is $22.8.


toggle

NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) absolute price change since previous trading day?

The absolute price change of NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) since the previous trading day is $0.94.


toggle

NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) percentage price change since previous trading day?

The percentage price change of NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) since the previous trading day is 4.3001%.


toggle

What is the most recent average sentiment score for NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ)?

The most recent average sentiment score for NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) is 56 out of 100.


toggle

What is the most recent average sentiment for NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ)?

The most recent sentiment for NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) is .


SEC-8K** Filing Available For NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

NAMSW (Newamsterdam Pharma Company N.V. WT)
ORMP (Oramed Pharma)
PHAR (Pharming Group N.V. ADR)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.